Characterization of myeloid-derived suppressor cells and cytokines GM-CSF, IL-10 and MCP-1 in dogs with malignant melanoma receiving a GD3-based immunotherapy-Reference-Cited by-同舟云学术

Characterization of myeloid-derived suppressor cells and cytokines GM-CSF, IL-10 and MCP-1 in dogs with malignant melanoma receiving a GD3-based immunotherapy

Published:2019-10 Issue: Volume:216 Page:109912
ISSN:0165-2427
Container-title:Veterinary Immunology and Immunopathology
language:en
Short-container-title:Veterinary Immunology and Immunopathology

Author:

Hutchison S,Sahay B,de Mello Souza CH,Sayour EJ,Lejeune A,Szivek A,Livaccari AM,Fox-Alvarez S,Salute M,Powers L,Milner RJ

Funder

University of Florida Small Animal Hospital

Olive’s Way Foundation and the Milner Comparative Oncology Lab

Publisher

Elsevier BV

Subject

General Veterinary,Immunology

Reference80 articles.

1. Development of an allogeneic whole-cell tumor vaccine expressing xenogeneic gp100 and its implementation in a phase II clinical trial in canine patients with malignant melanoma;Alexander;Cancer Immunol. Immunother. CII,2006

2. Magnitude of reactive thrombocytosis and associated clinical conditions in dogs;Athanasiou;Vet. Rec.,2017

3. Modulating T regulatory cells in cancer: how close are we?;Banerjee;Immunol. Cell Biol.,2013

4. Long-term survival of dogs with advanced malignant melanoma after DNA vaccination with xenogeneic human tyrosinase: a phase I trial;Bergman;Clin. Cancer Res.,2003

5. Analysis of the immunological cross reactivities of 213 well characterized monoclonal antibodies with specificities against various leucocyte surface antigens of human and 11 animal species;Brodersen;Vet. Immunol. Immunopathol.,1998

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bioactive sphingolipids as emerging targets for signal transduction in cancer development;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-09

2. Cancer mRNA vaccines: clinical advances and future opportunities;Nature Reviews Clinical Oncology;2024-05-17

3. Myeloid derived suppressor cells in peripheral blood can be a prognostic factor in canine transitional cell carcinoma;Veterinary Immunology and Immunopathology;2024-03

4. Chronic adrenergic stress and generation of myeloid‐derived suppressor cells: Implications for cancer immunotherapy in dogs;Veterinary and Comparative Oncology;2023-03-23

5. Relaxin contributes to the elevation of monocytic myeloid-derived suppressor cells in peripheral blood of pregnant canines;Journal of Reproductive Immunology;2023-02